Literature DB >> 33571287

Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy.

Andrew E Radbill1, Lucy Y Lei2, Sachin Y Paranjape3, Daniel J Blackwell3, Robert L Abraham4, Derek S Chew2, Satish R Raj2,3, Björn C Knollmann3.   

Abstract

AIMS: Arrhythmia mechanisms in hypertrophic cardiomyopathy remain uncertain. Preclinical models suggest hypertrophic cardiomyopathy-linked mutations perturb sarcomere length-dependent activation, alter cardiac repolarization in rate-dependent fashion and potentiate triggered electrical activity. This study was designed to assess rate-dependence of clinical surrogates of contractility and repolarization in humans with hypertrophic cardiomyopathy.
METHODS: All participants had a cardiac implantable device capable of atrial pacing. Cases had clinical diagnosis of hypertrophic cardiomyopathy, controls were age-matched. Continuous electrocardiogram and blood pressure were recorded during and immediately after 30 second pacing trains delivered at increasing rates.
RESULTS: Nine hypertrophic cardiomyopathy patients and 10 controls were enrolled (47% female, median 55 years), with similar baseline QRS duration, QT interval and blood pressure. Median septal thickness in hypertrophic cardiomyopathy patients was 18mm; 33% of hypertrophic cardiomyopathy patients had peak sub-aortic velocity >50mmHg. Ventricular ectopy occurred during or immediately after pacing trains in 4/9 hypertrophic cardiomyopathy patients and 0/10 controls (P = 0.03). During delivery of steady rate pacing across a range of cycle lengths, the QT-RR relationship was not statistically different between HCM and control groups; no differences were seen in subgroup analysis of patients with or without intact AV node conduction. Similarly, there was no difference between groups in the QT interval of the first post-pause recovery beat after pacing trains. No statistically significant differences were seen in surrogate measures for cardiac contractility.
CONCLUSION: Rapid pacing trains triggered ventricular ectopy in hypertrophic cardiomyopathy patients, but not controls. This finding aligns with pre-clinical descriptions of excessive cardiomyocyte calcium loading during rapid pacing, increased post-pause sarcoplasmic reticulum calcium release, and subsequent calcium-triggered activity. Normal contractility at all diastolic intervals argues against clinical significance of altered length-dependent myofilament activation.

Entities:  

Mesh:

Year:  2021        PMID: 33571287      PMCID: PMC7877626          DOI: 10.1371/journal.pone.0246768

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  14 in total

Review 1.  Clinical Course and Management of Hypertrophic Cardiomyopathy.

Authors:  Barry J Maron
Journal:  N Engl J Med       Date:  2018-08-16       Impact factor: 91.245

Review 2.  Sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Constantinos O'Mahony; Perry Elliott; William McKenna
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-09-28

3.  Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.

Authors:  Cordula M Wolf; Ivan P G Moskowitz; Scott Arno; Dorothy M Branco; Christopher Semsarian; Scott A Bernstein; Michael Peterson; Michael Maida; Gregory E Morley; Glenn Fishman; Charles I Berul; Christine E Seidman; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

4.  Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.

Authors:  A M Varnava; P M Elliott; C Baboonian; F Davison; M J Davies; W J McKenna
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.

Authors:  Lili Wang; Kyungsoo Kim; Shan Parikh; Adrian Gabriel Cadar; Kevin R Bersell; Huan He; Jose R Pinto; Dmytro O Kryshtal; Bjorn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2017-12-05       Impact factor: 5.000

Review 6.  Myofilament length dependent activation.

Authors:  Pieter P de Tombe; Ryan D Mateja; Kittipong Tachampa; Younss Ait Mou; Gerrie P Farman; Thomas C Irving
Journal:  J Mol Cell Cardiol       Date:  2010-01-04       Impact factor: 5.000

Review 7.  Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.

Authors:  Sabine Huke; Björn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2010-01-22       Impact factor: 5.000

8.  Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

Authors:  Franz Baudenbacher; Tilmann Schober; Jose Renato Pinto; Veniamin Y Sidorov; Fredrick Hilliard; R John Solaro; James D Potter; Björn C Knollmann
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

9.  Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.

Authors:  Vasco Sequeira; Paul J M Wijnker; Louise L A M Nijenkamp; Diederik W D Kuster; Aref Najafi; E Rosalie Witjas-Paalberends; Jessica A Regan; Nicky Boontje; Folkert J Ten Cate; Tjeerd Germans; Lucie Carrier; Sakthivel Sadayappan; Marjon A van Slegtenhorst; Ruud Zaremba; D Brian Foster; Anne M Murphy; Corrado Poggesi; Cris Dos Remedios; Ger J M Stienen; Carolyn Y Ho; Michelle Michels; Jolanda van der Velden
Journal:  Circ Res       Date:  2013-03-18       Impact factor: 17.367

10.  Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?

Authors:  Adaya Weissler-Snir; Paul Dorian; Harry Rakowski; Melanie Care; Danna Spears
Journal:  Heart Rhythm       Date:  2020-08-12       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.